Navigation Links
DEPC water from Mo Bio Laboratories, Inc.
Fetal Calf Serum from Quad Five
Pyrex brand narrow mouth graduated erlenmeyer flask, student grade from Sigma-Aldrich
Rabbit Anti-Bovine Xanthine Oxidase, Buttermilk Polyclonal Antibody, Horseradish Peroxidase Conjugated from Meridian Life Science, Inc.
Corning 2000 ml Erlenmeyer Flask, Pc, Baffled Bottom, Sterile from Sigma-Aldrich
Biology Products:
(Date:11/23/2009)...from Perth,s Telethon Institute for Child Health R...ing of alcohol consumption in pregnancy affects ch... just been published online in the international j...y said the analysis was drawn from a random sample...nnaire three months after the baby,s delivery, and...
(Date:11/23/2009)...is available in German . , A bit of imagina...t be a bad thing. It could help to add data from a...wever, it must do so constructively. In order to i...ith more than just imagination, physicists at the ...ted a theory of spatial perception called informat...
(Date:11/23/2009)...is available in German . , Of all global ca...in the atmosphere where it contributes to global w... terrestrial ecosystems such as forests, grassland...of aquatic and terrestrial ecosystems is considere...educing climate change. However, new greenhouse ga...
Breaking Biology News(10 mins):New study links alcohol in pregnancy to child behavior problems 2Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4Intensive land management leaves Europe without carbon sinks 2VIDEO from Medialink and CIGNA 3A Dont Stress Out Over Stress Some of it is Good for You 58857 1VIDEO from Medialink and CIGNA 3A Dont Stress Out Over Stress Some of it is Good for You 58857 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 1Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 2Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 3Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial 14351 4Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 1Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 2
...YORK, Feb. 19 Explorations Group Inc. (OTC Bullet...red Florida-based Hawk Biometric Technologies, Inc...he automotive, real estate and maritime industries...grates fingerprint scanning into a vehicle,s opera...ed drivers. Combined with optional GPS capabiliti...
...late 2007, hundreds of dead and stranded seabirds ...thers saturated with water and coated with an unkn...cientists determined that a massive "red tide" blo...substance that stripped the natural waterproofing ...cumented case of its kind, but similar events may ...
...ington, Virginia (Feb. 20, 2009) In a startling r...rnal Conservation Biology found that more than 8...m 1950-2000 occurred in regions identified as the ... Earth. , Titled "Warfare in Biodiversity Hotspot...n scientists compared major conflict zones with th...
Other Biology News:Explorations Group Acquires Hawk Biometric Technologies, Inc. 2Study links seabird deaths to soap-like foam produced by red-tide algae 2Study finds most wars occur in Earth's richest biological regions 2Study finds most wars occur in Earth's richest biological regions 3
(Date:11/24/2009)...CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)manag...areConference.TheconferencewillbeheldDecember1-2,2...nTuesday,December1at11:00a.m.EasternTimeinHolmes1(...beavailableat www.celltherapeutics.com ,anditwilla...yHealthCareConference,NewYorkPalaceHotel,Holmes1(4...
(Date:11/23/2009)...ication, computation and more powerful ways to enc...tum states as carriers of information is an extrem...wn, mathematically, how to gently tease out unwant...he information intact. Their work is reported in t...highlighted with a Viewpoint in Physics ( http:/...
(Date:11/23/2009)...Call/-YMBioSciencesInc.(NYSEAmex: YMI ;TSX:YM),ali...ndadvancesadiverseportfolioofpromisingcancer-relat...edthatCytopia(ASX:CYT)hascommencedenrollmentofaPha...teredJAK1/JAK2inhibitor.Thetrialisbeingconductedat...topiaintoYMhasbeenpreviouslyannouncedandispendinga...
(Date:11/23/2009)...gnC or p.(IDC)announcedtodaythatDr.BruceL.A.Carter...ssfultrackrec or dinbiotechnologyexecutivemanageme...tics,inSeattle,WAandChiefScientificOfficeratNovoN ...ww.newscom.com/cgi-bin/prnh/20091123/SF15228 ) ,...cercommented,"IamdelightedtowelcomeDr.BruceCartera...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2